← All trials
NCT01957995
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 8, 2013
- Primary completion
- May 29, 2014
- Completion date
- Jul 14, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 13
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- University of Southern CaliforniaLead sponsor
- University of Southern CaliforniaOverall official - principal investigator
- National Cancer Institute (NCI)Collaborator
- Jina Pharmaceuticals, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.